drugset / Trial / NCT00698789
Evaluate the Safety and Tolerability of INCB019602 When Administered With Metformin in Patients With Type 2 Diabetes
RandomizedParallel-groupDouble-blindTreatment
Summary
Determine the effect of treatment with INCB019602 administered as an add-on to stable dose metformin therapy in type 2 diabetic subjects on safety and glycemic control.
Timeline
- Start
- 2008-05
- Primary completion
- 2009-02
- Completion
- 2009-06
Outcome
Outcome not reported
Stopped: “Study ended after diabetes development plan review. .”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | INCB019602 | Unknown | 5 mg | — |
| Subject | INCB019602 | Unknown | 7.5 mg | — |
| Subject | INCB019602 | Unknown | 20 mg | — |
| Background | Metformin | Small molecule | — | — |